-
麦科奥特MT1002 II期临床研究，顺利完成全部试验参与者入组
Micot MT1002 Phase II Clinical Study Successfully Completes Enrollment of All Trial Participants
넶1 2026-05-14 -
乔迁新址 启新征程｜麦科奥特上海分公司圆满完成新址搬迁
Micot Shanghai Branch Completes New Office Relocation Successfully
넶1 2026-05-14 -
XTL3710项目核心指标大幅跃升，麦科奥特原料药部门多肽工艺革新取得重大突破
Key XTL3710 metrics skyrocket in Micot Bio\x26#39;s peptide process breakthrough
넶1 2026-05-12 -
抗凝逆转的“通用解药”：麦科奥特MT1011完成I期临床，剑指临床痛点
Universal Antidote for Anticoagulation Reversal: Micot\x26#39;s MT1011 Completes Phase I Clinical Trial, Targeting Unmet Clinic Needs
넶84 2026-04-29 -
麦科奥特MT2004核心专利获欧洲授权，全球知识产权壁垒再筑新高
Micot Bio Secures European Patent for MT2004，Strengthening Global IP Moat
넶109 2026-04-28
